Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab As the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
JOURNAL OF HEPATOCELLULAR CARCINOMA（2024）
Key words
unresectable hepatocellular carcinoma,transarterial chemoembolization,lenvatinib,tislelizumab,immunotherapy.
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined